Biotech · Private company
Sunesis Pharmaceuticals
Track this companyFree. Adds Sunesis Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- SNS-062Phase 2 · Chronic Lymphocytic LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid CancersPHASE1_PHASE2 · TERMINATED · started Apr 28, 2017ClinicalTrials.gov NCT03037645 · fetched Nov 12, 2026
- Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic SyndromesPHASE1 · COMPLETED · started Nov 22, 2013ClinicalTrials.gov NCT01913951 · fetched Nov 12, 2026
- Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic SyndromePHASE1_PHASE2 · COMPLETED · started Jul 18, 2013ClinicalTrials.gov NCT01893320 · fetched Nov 12, 2026